Home > Boards > US Listed > Biotechs >

CytomX Therapeutics, Inc. (CTMX)

Add CTMX Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 3/7/2018 6:09:06 PM - Followers: 4 - Board type: Free - Posts Today: 0

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition, it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., ImmunoGen, Inc., and The University of Texas M. D. Anderson Cancer Center to develop selected Probody therapeutics. The company was founded in 2008 and is headquartered in South San Francisco, California.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTMX News: CytomX Therapeutics Announces Technology Acquisition From Agensys, Inc., an Affiliate of Astellas Pharma Inc. 01/07/2019 08:00:00 AM
CTMX News: Statement of Changes in Beneficial Ownership (4) 12/27/2018 12:44:39 PM
CTMX News: Initial Statement of Beneficial Ownership (3) 12/27/2018 12:42:27 PM
CTMX News: Current Report Filing (8-k) 12/20/2018 08:08:05 AM
CTMX News: CytomX Therapeutics Announces Changes to its Board of Directors 12/20/2018 08:00:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#11   PFE dumps CTMX collaboration: #msg-139113088. DewDiligence 03/07/18 06:09:06 PM
#10   Has this company any drugs in the market? manisero66 03/03/18 12:20:40 PM
#9   $CTMX entering runway to the launchpad. ??. Few Maxgambit 11/17/17 11:46:20 AM
#8   CTMX $41 price target fl89808 10/04/17 12:54:33 PM
#7   Up 35% after hours! fl89808 10/03/17 08:00:05 PM
#6   Enough cash in the bank until 2020 as fl89808 08/08/17 10:08:54 PM
#4   $200 million in the bank. No cash raises fl89808 06/04/17 10:18:27 AM
#3   "As of March 31, 2017, CytomX had cash, fl89808 05/05/17 10:10:17 AM
#2   Bristol-Myers Squibb Company BMY and CytomX Therapeutics, Inc. fl89808 03/21/17 08:05:26 PM
#1   $200M up front payment coming with 36.5 million fl89808 03/20/17 08:06:01 PM